10:35 :
Novartis falls 4% on MS drug concerns -
BOSTON (MarketWatch) -- Shares of Swiss drug maker Novartis AG fell 4% early Friday on reports that European regulators were looking into the cardiovascular safety of its recently approved multiple sclerosis treatment Gilenya. Shares of ...